| Application no. and date | 21186643.9 (espacenet) (Federated) (European Patent Register), 20180730 | | Patent/reg. no. and date | DK/EP 3960740, 20231115 | | Publication date | 20220302 | | Priority no. and date | US 201762539822 P, 20170801 | | EP pub. no. and date |
EP 3960740 20220302 | | Effective date | | | Applicant/owner | Gilead Sciences, Inc., 333 Lakeside Drive
Foster City, CA 94404, US | | Applicant ref. no. | | | Inventor | SHI, Bing,
Foster City, 94404, US,
LAPINA, Olga Viktorovna,
Foster City, 94404, US,
WANG, Silas,
Foster City, 94404, US | | Representative | | | Opponent | | | IPC Class | A61K 31/5365 (2006.01) , A61K 31/5377 (2006.01) , A61K 31/635 (2006.01) , A61K 31/675 (2006.01) , A61P 31/18 (2006.01) , C07D 417/12 (2006.01) , C07D 473/34 (2006.01) , C07D 493/04 (2006.01) , C07D 498/14 (2006.01) , C07H 19/16 (2006.01) , C07H 19/20 (2006.01) | | Title | CRYSTALLINE FORMS OF ETHYL ((S)-((((2R,5R)-5-(6-AMINO-9H-PURIN-9-YL)-4-FLUORO-2,5-DIHYDROFURAN-2-YL)OXY)METHYL)(PHENOXY)PHOSPHORYL)-L-ALANINATE (GS-9131) VANILLATE FOR TREATING VIRAL INFECTIONS | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
